acetylcysteine has been researched along with Nerve Degeneration in 50 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (4.00) | 18.2507 |
2000's | 30 (60.00) | 29.6817 |
2010's | 16 (32.00) | 24.3611 |
2020's | 2 (4.00) | 2.80 |
Authors | Studies |
---|---|
Albertini, G; Bentea, E; Deneyer, L; Massie, A | 1 |
Alandes, S; Alcácer, J; Banacloche, S; Benlloch, M; Colomer, N; Coronado, JA; Drehmer, E; Estrela, JM; Jihad-Jebbar, A; López-Blanch, R; Marchio, P; Obrador, E; Rivera, P; Salvador, R; Vallés, SL | 1 |
Abramov, AY; Antoine, DJ; Aronica, E; Balosso, S; Del Giudice, E; Liang, LP; Pascente, R; Pastore, A; Patel, M; Pauletti, A; Ravizza, T; Rizzi, M; Salamone, A; Shekh-Ahmad, T; Terrone, G; van Vliet, EA; Vezzani, A; Villa, BR; Walker, MC | 1 |
Dexter, DT; Harrison, IF; Powell, NM | 1 |
Ding, K; Fang, J; Wang, HD; Zhou, XM; Zhou, Y; Zhu, L | 1 |
Goldstein, BJ; Goncalves, S | 1 |
Bian, ZC; Guan, JL; Liang, CC; Wang, C; Zhu, Y | 1 |
Bury, A; Dexter, DT; Elson, JL; Harrison, IF; Pienaar, IS; Simon, AK; Woll, P | 1 |
Angelatou, F; Antonopoulos, I; Botsakis, K; Georgiou, CD; Grintzalis, K; Margarity, M; Matsokis, NA; Panagopoulos, NT; Theodoritsi, S | 1 |
Han, J; Leak, RK; Mason, DM; Nouraei, N; Weilnau, JN; Zarger, L | 1 |
Jankovic, J; Kondo, S; Le, W; Pan, T; Xie, W; Zhu, W | 1 |
Du, Y; Fan, X; Le, W; Li, X; Luo, G; Yang, D | 1 |
Hashimoto, T; Ibuki, T; Iwanaga, T; Kishibuchi, R; Kitagawa, H; Mizuguchi, H; Momota, H; Nishihara, S; Onaka, Y; Sado, M; Wada, D; Watanabe, TK; Yamasaki, Y | 1 |
Du, Y; Fan, X; Le, W; Li, L; Li, T; Luo, G; Wang, Q; Wang, Y; Yang, D; Zhang, X | 1 |
Druse, MJ; Sheth, DS; Tajuddin, NF | 1 |
Castaño, A; Gavilán, E; Gavilán, MP; Jiménez, S; Pintado, C; Ríos, RM; Ruano, D; Vitorica, J | 1 |
Andersen, JK; Jankovic, J; Kaur, D; Le, W; Li, X; Luo, F; Xie, W; Zhu, W | 1 |
Jackson, T; Jengelley, TA; Jnobaptiste, R; McNaught, KS | 1 |
Jankovic, J; Le, W; Li, C; Li, X; Xie, W; Zhu, W | 1 |
Colakoglu, N; Karlidag, T; Kaygusuz, I; Sapmaz, E; Yalcin, S; Yildiz, M | 1 |
Hart, A; Terenghi, G; Wiberg, M | 1 |
Jankovic, J; Kansara, S; Le, WD; Li, XP; Xie, WJ; Zhang, Z | 1 |
Castaño, A; García-Cuervo, L; Gavilán, E; Gavilán, MP; Gutiérrez, A; Pintado, C; Ríos, RM; Ruano, D; Vitorica, J | 1 |
Jantas, D; Konieczny, J; Kuśmierczyk, J; Lasoń, W; Lenda, T; Lorenc-Koci, E; Roman, A | 1 |
Adams, J; Dave, JR; Elliott, PJ; Hale, SL; Moffett, JR; Tortella, FC; Williams, AJ | 1 |
Coleman, MP; Laser, H; Mack, TG; Wagner, D | 1 |
Hart, AM; Kellerth, JO; Terenghi, G; Wiberg, M | 1 |
Guerra, MJ; Labandeira-Garcia, JL; Muñoz, AM; Rey, P; Soto-Otero, R | 1 |
Barbosa, E; Paintlia, AS; Paintlia, MK; Singh, AK; Singh, I | 1 |
Le, W; Pan, T; Qu, S; Wang, X; Xie, W; Zhang, X | 1 |
Halliwell, B; Hyun, DH; Jenner, P; Lee, M | 1 |
Aoyama, K; Chan, WY; Chen, Y; Hamby, AM; Liu, J; Suh, SW; Swanson, RA | 1 |
Hazell, AS; Hoover, R; McIntosh, TK; Yi, JH | 1 |
Hausott, B; Ingorokva, S; Klimaschewski, L; Pfaller, K | 1 |
Arakawa, M; Ishige, K; Ito, Y; Oda, T; Osada, N; Ushimaru, N | 1 |
Grünblatt, E; Mandel, S; Youdim, MB | 1 |
Lim, HS; Lu, XY; Paz, J; Yao, H; Zhang, W | 1 |
Inayat-Hussain, SH; Ross, D; Zafar, KS | 1 |
Fukui, K; Kawataki, T; Koike, T; Yang, Y | 1 |
Fridkin, M; Jankovic, J; Le, W; Pan, T; Xie, W; Xu, P; Youdim, MB; Zheng, H; Zhu, W | 1 |
Le, W; Li, L; Li, X; Ming, M; Peng, C; Yang, D | 1 |
Burigo, M; Constantino, L; Dal-Pizzol, F; Di-Pietro, PB; Dias, ML; Machado, RA; Scaini, G; Streck, EL | 1 |
Jankovic, J; Le, W; Li, J; Pan, T; Xie, W; Youdim, MB; Zhu, W | 1 |
Ballard, C; Iravani, MM; Jenner, P; MacInnes, N; Perry, E; Perry, R; Piggott, M | 1 |
Chen, S; Du, Y; Huang, K; Le, W; Li, X; Yang, D; Zhang, X | 1 |
Bristol, LA; Brown, RH; Hosler, B; Kuncl, RW; Rothstein, JD | 1 |
Henderson, JT; Javaheri, M; Kopko, S; Roder, JC | 1 |
Chong, YH; Montelaro, RC; Park, HK; Shin, SA; Sung, JH | 1 |
Amarnath, V; Montine, TJ; Olson, SJ; Ou, JJ; Sidell, KR; Zhang, Y | 1 |
Amamath, V; Montine, TJ; Sidell, KR | 1 |
2 review(s) available for acetylcysteine and Nerve Degeneration
Article | Year |
---|---|
The nerve injury and the dying neurons: diagnosis and prevention.
Topics: Acetylcarnitine; Acetylcysteine; Animals; Axons; Cell Death; Cell Dedifferentiation; Humans; Nerve Degeneration; Nerve Growth Factors; Nerve Regeneration; Neurons; Neurons, Afferent; Neuroprotective Agents; Peripheral Nerve Injuries; Recovery of Function; Schwann Cells; Signal Transduction | 2011 |
Dopamine thioethers in neurodegeneration.
Topics: Acetylcysteine; Animals; Corpus Striatum; Dopamine; Humans; Nerve Degeneration; Neurodegenerative Diseases; Sulfides | 2001 |
48 other study(ies) available for acetylcysteine and Nerve Degeneration
Article | Year |
---|---|
Systemic LPS-induced neuroinflammation increases the susceptibility for proteasome inhibition-induced degeneration of the nigrostriatal pathway.
Topics: Acetylcysteine; Animals; Behavior, Animal; Corpus Striatum; Cysteine Proteinase Inhibitors; Disease Models, Animal; Illness Behavior; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Microglia; Nerve Degeneration; Neural Pathways; Proteasome Inhibitors; Substantia Nigra | 2019 |
Nicotinamide Riboside and Pterostilbene Cooperatively Delay Motor Neuron Failure in ALS SOD1
Topics: Acetylcysteine; Amyotrophic Lateral Sclerosis; Animals; Antioxidants; Apoptosis; Cytokines; Female; Male; Metabolome; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria; Motor Activity; Motor Neurons; Mutation; NAD; Nerve Degeneration; NF-E2-Related Factor 2; Niacinamide; Oxidation-Reduction; Pyridinium Compounds; Reactive Oxygen Species; Sirtuin 1; Sirtuin 3; Spinal Cord; Stilbenes; Superoxide Dismutase-1; Survival Analysis | 2021 |
Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy.
Topics: Acetylcysteine; Animals; Astrocytes; Biomarkers; Cognitive Dysfunction; Disease Models, Animal; Drug Therapy, Combination; Epilepsy; Hippocampus; HMG-Box Domains; HMGB1 Protein; Isothiocyanates; Male; Nerve Degeneration; Neurons; Oxidative Stress; Rats; Sulfoxides | 2017 |
The histone deacetylase inhibitor nicotinamide exacerbates neurodegeneration in the lactacystin rat model of Parkinson's disease.
Topics: Acetylation; Acetylcysteine; Animals; Cell Death; Disease Models, Animal; Dopaminergic Neurons; Histone Deacetylase Inhibitors; Male; Nerve Degeneration; Niacinamide; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley | 2019 |
N-acetylcysteine amide provides neuroprotection via Nrf2-ARE pathway in a mouse model of traumatic brain injury.
Topics: Acetylcysteine; Animals; Antioxidant Response Elements; Antioxidants; Apoptosis; Behavior, Animal; Brain; Brain Injuries, Traumatic; Caspase 3; Disease Models, Animal; Heme Oxygenase-1; Male; Membrane Proteins; Mice, Inbred ICR; NAD(P)H Dehydrogenase (Quinone); Nerve Degeneration; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Signal Transduction; Time Factors | 2018 |
Acute N-Acetylcysteine Administration Ameliorates Loss of Olfactory Neurons Following Experimental Injury In Vivo.
Topics: Acetylcysteine; Animals; Cell Survival; Mice; Nerve Degeneration; Neuroprotective Agents; Olfactory Bulb; Olfactory Mucosa; Olfactory Receptor Neurons | 2020 |
FIP200 is required for maintenance and differentiation of postnatal neural stem cells.
Topics: Acetylcysteine; Age Factors; Animals; Animals, Newborn; Apoptosis; Autophagy; Autophagy-Related Proteins; Bromodeoxyuridine; Cell Differentiation; Cerebral Ventricles; Chloroquine; Dentate Gyrus; Dicarbethoxydihydrocollidine; Embryo, Mammalian; Gene Expression Regulation, Developmental; Glial Fibrillary Acidic Protein; In Situ Nick-End Labeling; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Electron, Transmission; Microtubule-Associated Proteins; Mutation; Nerve Degeneration; Neural Cell Adhesion Molecule L1; Neural Stem Cells; Reactive Oxygen Species; Sialic Acids; SOXB1 Transcription Factors; Transcription Factor TFIIH; Transcription Factors; Tumor Suppressor Protein p53 | 2013 |
An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease.
Topics: Acetylcysteine; Analysis of Variance; Animals; Antibodies, Monoclonal; Calcium-Binding Proteins; Cell Count; Choline O-Acetyltransferase; Cholinergic Neurons; Cysteine Proteinase Inhibitors; Disease Models, Animal; Forelimb; Functional Laterality; Image Processing, Computer-Assisted; Laser Capture Microdissection; Magnetic Resonance Imaging; Male; Membrane Proteins; Motor Activity; Muscle Proteins; Nerve Degeneration; Parkinson Disease; Pedunculopontine Tegmental Nucleus; Phosphopyruvate Hydratase; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase | 2015 |
17β-Estradiol/N-acetylcysteine interaction enhances the neuroprotective effect on dopaminergic neurons in the weaver model of dopamine deficiency.
Topics: Acetylcysteine; Animals; Dopaminergic Neurons; Drug Synergism; Estradiol; Female; Immunohistochemistry; Male; Mice; Mice, Neurologic Mutants; Nerve Degeneration; Neuroprotective Agents; Parkinsonian Disorders | 2016 |
Investigation of the therapeutic potential of N-acetyl cysteine and the tools used to define nigrostriatal degeneration in vivo.
Topics: Acetylcysteine; Animals; Corpus Striatum; Male; Mice; Nerve Degeneration; Neuroprotective Agents; Oxidopamine; Substantia Nigra | 2016 |
Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement.
Topics: Acetylcysteine; Animals; Autophagy; Cells, Cultured; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neuroprotective Agents; Parkinson Disease; PC12 Cells; Protein Folding; Rats; Sirolimus | 2008 |
c-Jun N-terminal kinase mediates lactacystin-induced dopamine neuron degeneration.
Topics: Acetylcysteine; Animals; Apoptosis; Blotting, Western; Caspase 3; Cell Line; Chromatography, High Pressure Liquid; Cysteine Proteinase Inhibitors; Cytochromes c; Dopamine; Immunohistochemistry; JNK Mitogen-Activated Protein Kinases; Male; Nerve Degeneration; Neurons; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Substantia Nigra; Tetrazolium Salts; Thiazoles | 2008 |
Protective effect against Parkinson's disease-related insults through the activation of XBP1.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Acetylcysteine; Animals; Cell Death; Cell Line; Cell Survival; Cysteine Proteinase Inhibitors; DNA-Binding Proteins; Dopamine; Endoplasmic Reticulum; Endoribonucleases; Humans; Leupeptins; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neurons; Parkinsonian Disorders; Protein Serine-Threonine Kinases; Regulatory Factor X Transcription Factors; RNA, Messenger; Signal Transduction; Stress, Physiological; Transcription Factors; X-Box Binding Protein 1 | 2009 |
An insight into the mechanistic role of p53-mediated autophagy induction in response to proteasomal inhibition-induced neurotoxicity.
Topics: Acetylcysteine; Apoptosis; Autophagy; Cell Line, Tumor; Cytoprotection; Dopamine; Enzyme Inhibitors; Humans; Mitochondria; Nerve Degeneration; Neurons; Phagosomes; Phosphorylation; Proteasome Inhibitors; Protein Processing, Post-Translational; Sirolimus; Time Factors; Tumor Suppressor Protein p53 | 2009 |
Antioxidant neuroprotection against ethanol-induced apoptosis in HN2-5 cells.
Topics: Acetylcysteine; Alcohol-Induced Disorders, Nervous System; Animals; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Cell Line; Central Nervous System Depressants; Cytoprotection; Ethanol; Female; Gene Expression Regulation; Hippocampus; Melatonin; Mice; Nerve Degeneration; Neuroprotective Agents; Oxidative Stress; Pregnancy; Prenatal Exposure Delayed Effects; Reactive Oxygen Species | 2009 |
Dysfunction of the unfolded protein response increases neurodegeneration in aged rat hippocampus following proteasome inhibition.
Topics: Acetylcysteine; Aging; Animals; Biomarkers; Caspase 3; Enzyme Inhibitors; Hippocampus; Male; Nerve Degeneration; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Signal Transduction; Unfolded Protein Response | 2009 |
Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degeneration.
Topics: Acetylcysteine; Animals; Apoferritins; Cation Transport Proteins; Chelation Therapy; Corpus Striatum; Cysteine Proteinase Inhibitors; Cytoprotection; Dopamine; Gene Expression Regulation; Genetic Therapy; Iron Metabolism Disorders; Mice; Mice, Transgenic; Nerve Degeneration; Neurons; Parkinson Disease; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Substantia Nigra | 2010 |
The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease.
Topics: Acetylcysteine; Animals; Blotting, Western; Canavanine; Cell Survival; Cells, Cultured; Cysteine Proteinase Inhibitors; Dopamine; Immunohistochemistry; Locus Coeruleus; Male; Nerve Degeneration; Neurons; Oxidative Stress; Parkinson Disease; Proteasome Endopeptidase Complex; Protein Folding; Rats; Rats, Sprague-Dawley; Rotenone; Substantia Nigra; Ubiquitin-Activating Enzymes; Ubiquitin-Conjugating Enzymes; Uncoupling Agents | 2010 |
Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease.
Topics: Acetylcysteine; Animals; Behavior, Animal; Blotting, Western; Cell Count; Chromatography, High Pressure Liquid; Dopamine; Fluorescent Antibody Technique; Immunohistochemistry; Iron; Male; Mice; Mice, Inbred C57BL; Microinjections; Microscopy, Electron; Nerve Degeneration; Neurons; Neuroprotective Agents; Parkinson Disease, Secondary; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Substantia Nigra; Ubiquitin | 2010 |
Evaluation of the effect of methylprednisolone and N-acetylcystein on anastomotic degeneration and regeneraton of the facial nerve.
Topics: Acetylcysteine; Anastomosis, Surgical; Animals; Anti-Inflammatory Agents; Cell Proliferation; Facial Nerve; Female; Free Radical Scavengers; Methylprednisolone; Microscopy, Electron; Nerve Degeneration; Nerve Regeneration; Neuroglia; Rabbits; Schwann Cells | 2012 |
A mechanistic study of proteasome inhibition-induced iron misregulation in dopamine neuron degeneration.
Topics: Acetylcysteine; Antigens, CD; Blotting, Western; Cell Line; Cell Survival; Cysteine Proteinase Inhibitors; Dopaminergic Neurons; Ferritins; Genetic Vectors; Humans; Immunoprecipitation; Iron; Iron Metabolism Disorders; Iron-Regulatory Proteins; Lentivirus; Nerve Degeneration; Proteasome Endopeptidase Complex; Reactive Oxygen Species; Receptors, Transferrin; RNA, Small Interfering | 2012 |
Lipopolysaccharide-induced neuroinflammation leads to the accumulation of ubiquitinated proteins and increases susceptibility to neurodegeneration induced by proteasome inhibition in rat hippocampus.
Topics: Acetylcysteine; Aging; Animals; Drug Synergism; Hippocampus; Inflammation; Lipopolysaccharides; Male; Nerve Degeneration; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Rats; Rats, Wistar; Ubiquitination | 2012 |
The extent of neurodegeneration and neuroprotection in two chemical in vitro models related to Parkinson's disease is critically dependent on cell culture conditions.
Topics: Acetylcysteine; Cell Death; Cell Differentiation; Cell Survival; Cells, Cultured; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Drug Interactions; Humans; Nerve Degeneration; Neuroprotective Agents; Parkinson Disease; Pentacyclic Triterpenes; Rotenone; Time Factors; Tretinoin; Triterpenes | 2013 |
Delayed treatment with MLN519 reduces infarction and associated neurologic deficit caused by focal ischemic brain injury in rats via antiinflammatory mechanisms involving nuclear factor-kappaB activation, gliosis, and leukocyte infiltration.
Topics: Acetylcysteine; Animals; Astrocytes; Brain Ischemia; Cell Movement; Cysteine Endopeptidases; Gliosis; Infarction, Middle Cerebral Artery; Inflammation Mediators; Leukocytes; Male; Multienzyme Complexes; Nerve Degeneration; Nervous System Diseases; NF-kappa B; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Recovery of Function | 2003 |
Proteasome inhibition arrests neurite outgrowth and causes "dying-back" degeneration in primary culture.
Topics: Acetylcysteine; Animals; Cell Division; Cell Survival; Cells, Cultured; Cysteine Endopeptidases; Growth Inhibitors; Mice; Mice, Inbred C57BL; Multienzyme Complexes; Nerve Degeneration; Neural Inhibition; Neurites; PC12 Cells; Proteasome Endopeptidase Complex; Rats | 2003 |
Sensory neuroprotection, mitochondrial preservation, and therapeutic potential of N-acetyl-cysteine after nerve injury.
Topics: Acetylcysteine; Animals; Axotomy; Dose-Response Relationship, Drug; Ganglia, Spinal; In Situ Nick-End Labeling; Lumbosacral Region; Male; Microscopy, Electron; Mitochondria; Nerve Degeneration; Neurons, Afferent; Neuroprotective Agents; Rats; Sciatic Nerve | 2004 |
Systemic administration of N-acetylcysteine protects dopaminergic neurons against 6-hydroxydopamine-induced degeneration.
Topics: Acetylcysteine; Animals; Antigens, CD; Antigens, Neoplasm; Antigens, Surface; Ascorbic Acid; Avian Proteins; Basigin; Blood Proteins; Cell Count; Corpus Striatum; Cysteine; Dopamine; Drug Administration Routes; Female; Fluoresceins; Fluorescent Dyes; Free Radical Scavengers; Glial Fibrillary Acidic Protein; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Hydroxydopamines; Immunohistochemistry; Membrane Glycoproteins; Nerve Degeneration; Neurons; Organic Chemicals; Phosphopyruvate Hydratase; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase | 2004 |
N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Acetylcysteine; Age Factors; Analysis of Variance; Animals; Animals, Newborn; Antigens; CD11b Antigen; Cell Count; Cell Death; Cytokines; Demyelinating Diseases; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Female; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Infant, Newborn; Leukomalacia, Periventricular; Lipopolysaccharides; Male; Myelin Basic Protein; Nerve Degeneration; Neuroprotective Agents; O Antigens; Oligodendroglia; Pregnancy; Proteoglycans; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor alpha; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stem Cells; Survival Rate; Time Factors; Transcription Factors | 2004 |
Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration.
Topics: Acetylcysteine; Animals; Deferoxamine; Iron Chelating Agents; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neuroprotective Agents; Parkinsonian Disorders; Proteasome Inhibitors; Substantia Nigra; Treatment Outcome; Ubiquitin | 2005 |
Effect of overexpression of wild-type or mutant parkin on the cellular response induced by toxic insults.
Topics: 1-Methyl-4-phenylpyridinium; Acetylcysteine; Aldehydes; Apoptosis; Cell Death; Cell Line, Tumor; Drug Resistance; Enzyme Inhibitors; Genetic Predisposition to Disease; Glutamic Acid; Guanine; Humans; Hydrogen Peroxide; Mutation; Nerve Degeneration; Neurons; Neurotoxins; Oxidative Stress; Parkinsonian Disorders; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Substantia Nigra; Tyrosine; Ubiquitin-Protein Ligases | 2005 |
Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse.
Topics: Acetylcysteine; Aging; Animals; Behavior, Animal; Bicuculline; Blotting, Western; Brain; Cysteine; Excitatory Amino Acid Transporter 3; GABA Antagonists; Genotype; Glutathione; Immunohistochemistry; Mice; Mice, Knockout; Nerve Degeneration; Neurons; Oxidants; Oxidative Stress | 2006 |
Early, transient increase in complexin I and complexin II in the cerebral cortex following traumatic brain injury is attenuated by N-acetylcysteine.
Topics: Acetylcysteine; Adaptor Proteins, Vesicular Transport; Animals; Brain Injuries; Cerebral Cortex; Disease Models, Animal; Free Radical Scavengers; Glutamic Acid; Hippocampus; Male; Nerve Degeneration; Nerve Tissue Proteins; Neurotoxins; Oxidative Stress; Rats; Rats, Sprague-Dawley; SNARE Proteins; Synaptic Membranes; Synaptic Transmission; Time Factors; Up-Regulation | 2006 |
Constitutively expressed catalytic proteasomal subunits are up-regulated during neuronal differentiation and required for axon initiation, elongation and maintenance.
Topics: Acetylcysteine; Animals; Animals, Newborn; Catalytic Domain; Cell Differentiation; Cell Survival; Cysteine Proteinase Inhibitors; Enzyme Inhibitors; Ganglia, Autonomic; Ganglia, Sensory; Growth Cones; Microscopy, Electron, Scanning; Nerve Degeneration; Nerve Growth Factor; Nerve Net; Nervous System; PC12 Cells; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Rats; RNA, Messenger; Up-Regulation | 2006 |
N-acetylcysteine selectively protects cerebellar granule cells from 4-hydroxynonenal-induced cell death.
Topics: Acetylcysteine; Aldehydes; Animals; Animals, Newborn; Antioxidants; Brain; Cell Death; Cells, Cultured; Cerebellum; Free Radical Scavengers; Glutathione; L-Lactate Dehydrogenase; Mitochondrial Membranes; Nerve Degeneration; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Neurotoxins; Oxidative Stress; Plant Extracts; Rats; Rats, Wistar | 2006 |
The copper chelator, D-penicillamine, does not attenuate MPTP induced dopamine depletion in mice.
Topics: Acetylcysteine; Animals; Chelating Agents; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dopamine Agents; Iron; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Nerve Degeneration; Neuroprotective Agents; Penicillamine; Salicylic Acid | 2007 |
The neuroprotective role of attractin in neurodegeneration.
Topics: 1-Methyl-4-phenylpyridinium; Acetylcysteine; Analysis of Variance; Apoptosis Inducing Factor; Cell Line, Tumor; Cell Survival; Cytochromes c; Gene Expression Regulation; Humans; In Situ Hybridization; Membrane Proteins; Nerve Degeneration; Neurotoxins; RNA, Small Interfering; Transfection; Tyrosine 3-Monooxygenase | 2007 |
A comparative study of proteasomal inhibition and apoptosis induced in N27 mesencephalic cells by dopamine and MG132.
Topics: Acetylcysteine; Animals; Apoptosis; Caspases; Cell Line, Transformed; Cysteine Proteinase Inhibitors; Dopamine; Dose-Response Relationship, Drug; Enzyme Activation; Leupeptins; Mesencephalon; Nerve Degeneration; Neurons; Oxidative Stress; Parkinson Disease; Proteasome Endopeptidase Complex; Rats; Reactive Oxygen Species; Substantia Nigra | 2007 |
Cellular Zn2+ chelators cause "dying-back" neurite degeneration associated with energy impairment.
Topics: Acetylcysteine; Adenosine Triphosphate; Animals; Chelating Agents; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Energy Metabolism; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neuritis; Organ Culture Techniques; Superior Cervical Ganglion; Time Factors | 2007 |
Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators.
Topics: Acetylcysteine; Animals; Blood-Brain Barrier; Dopamine; Goats; Hydroxyquinolines; Iron Chelating Agents; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neurons; Rabbits; Substantia Nigra | 2007 |
Glial cell-derived neurotrophic factor protects against proteasome inhibition-induced dopamine neuron degeneration by suppression of endoplasmic reticulum stress and caspase-3 activation.
Topics: Acetylcysteine; Animals; Apoptosis; Caspase 3; Cells, Cultured; Dopamine; Endoplasmic Reticulum; Enzyme Activation; Glial Cell Line-Derived Neurotrophic Factor; Humans; Inclusion Bodies; Nerve Degeneration; Neurons; Parkinson Disease; Proteasome Inhibitors; Rats; Recombinant Proteins | 2007 |
Inhibition of brain creatine kinase activity after renal ischemia is attenuated by N-acetylcysteine and deferoxamine administration.
Topics: Acetylcysteine; Animals; Antioxidants; Brain; Brain Diseases, Metabolic; Creatine Kinase; Deferoxamine; Down-Regulation; Ischemia; Kidney Diseases; Male; Nerve Degeneration; Oxidative Stress; Rats; Rats, Wistar; Subcellular Fractions; Time Factors; Treatment Outcome; Uremia | 2008 |
Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degeneration.
Topics: Acetylcysteine; Animals; Dopamine; Indans; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neuroprotective Agents; Selegiline | 2008 |
Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems.
Topics: Acetylcholine; Acetylcysteine; Aged; Aged, 80 and over; alpha-Synuclein; Animals; Basal Nucleus of Meynert; Cell Death; Cells, Cultured; Cerebral Cortex; Cholinergic Fibers; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Lewy Bodies; Lewy Body Disease; Male; Nerve Degeneration; Nerve Tissue Proteins; Neural Pathways; Oligopeptides; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Rats; Rats, Sprague-Dawley; Ubiquitin | 2008 |
Multiple molecular pathways are involved in the neuroprotection of GDNF against proteasome inhibitor induced dopamine neuron degeneration in vivo.
Topics: Acetylcysteine; Animals; Cysteine Proteinase Inhibitors; Disease Models, Animal; Dopamine; Glial Cell Line-Derived Neurotrophic Factor; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase Kinases; Nerve Degeneration; p38 Mitogen-Activated Protein Kinases; Parkinson Disease; Phosphatidylinositol 3-Kinases; Proteasome Inhibitors; Proto-Oncogene Proteins c-akt; Random Allocation; Signal Transduction; Substantia Nigra | 2008 |
Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons.
Topics: Acetylcysteine; Amyotrophic Lateral Sclerosis; Animals; Animals, Newborn; Anti-Anxiety Agents; Antioxidants; Apoptosis; Base Sequence; Benzodiazepines; Biological Transport; Choline O-Acetyltransferase; Chromans; Ditiocarb; Glutamates; Glutamic Acid; Humans; Molecular Sequence Data; Motor Neurons; Nerve Degeneration; Neurotoxins; Oligonucleotides, Antisense; Organ Culture Techniques; Piperazines; Rats; Spinal Cord; Superoxide Dismutase | 1994 |
Reduction of lower motor neuron degeneration in wobbler mice by N-acetyl-L-cysteine.
Topics: Acetylcysteine; Animals; Facial Nerve; Forelimb; Free Radical Scavengers; Glutathione Peroxidase; Mice; Mice, Neurologic Mutants; Motor Neurons; Muscle, Skeletal; Neck; Nerve Degeneration; Spinal Cord | 1996 |
Protective effect of glutathione in HIV-1 lytic peptide 1-induced cell death in human neuronal cells.
Topics: Acetylcysteine; AIDS Dementia Complex; Amino Acid Sequence; Amino Acid Substitution; Antioxidants; Apoptosis; Cell Death; Cells, Cultured; Glutathione; HIV Envelope Protein gp41; HIV-1; Humans; Intracellular Membranes; Membrane Potentials; Mitochondria; Molecular Sequence Data; Nerve Degeneration; Neuroblastoma; Neurons; Neuroprotective Agents; Oxidation-Reduction; Peptide Fragments; Prodrugs; Tumor Cells, Cultured | 2001 |
Cysteine and mercapturate conjugates of oxidized dopamine are in human striatum but only the cysteine conjugate impedes dopamine trafficking in vitro and in vivo.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Animals; Brain; Cells, Cultured; Corpus Striatum; Cysteine; Dopamine; Esters; Female; Fetus; Humans; In Vitro Techniques; Male; Mesencephalon; Microdialysis; Nerve Degeneration; Oxidation-Reduction; Parkinson Disease; Rats; Rats, Sprague-Dawley; Synaptosomes | 2001 |